DICERNA PHARMACEUTICALS
Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, along with cancers, and other therapeutic areas to address liver problems. It is using ribonucleic acid interference (RNA) technology platform to develop its products. The product candidates are DCR-PHXC (for primary hyperoxaluria), DCR-undisclosed (for orphan genetic disease), DCR-PCSK9 (for cardiovascular disease), and DCR-HBV (for hepatitis B virus) among others. The company was founded in 2007 and is headquartered in Lexington, Massachusetts.
DICERNA PHARMACEUTICALS
Industry:
Biotechnology Genetics Health Care Pharmaceutical
Founded:
2007-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.dicerna.com
Total Employee:
101+
Status:
Closed
Contact:
6176126254
Email Addresses:
[email protected]
Total Funding:
271.45 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Domain Not Resolving Wordpress Plugins Sitelinks Search Box
Similar Organizations
A2A Pharmaceuticals
A2A Pharmaceuticals is a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents.
Accera
Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases.
Adcentrx Therapeutics
Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases
AGTC
AGTC is a biotechnology company conducting human clinical trials of AAV-based gene therapies for the treatment of rare diseases.
Aridis Pharmaceuticals
Aridis is a biopharmaceutical company focused on the development of novel, differentiated therapies for infectious diseases.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Biophytis
Biophytis is a research company that focuses on the fields of metabolic and age-related diseases.
Biosystems International
Biosystems International is a biotechnology company engaged in the development of blood-based diagnostics for cancer and chronic diseases.
CardioFocus
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Emerillon Therapeutics
Emerillon therapeutics is a biotechnology firm focused on the creation of innovative drug products for the treatment of infectious disease.
EquiTech Therapeutics, LLC
EquiTech Therapeutics, LLC's is a pioneer in the forward development of CRISPR-Cas9 genome editing for equine diseases and therapies.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Genecure
GeneCure is a biotechnology company providing treatments for life-threatening human diseases.
Homology Medicines
Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.
MagicMed Industries
MagicMed Industries is a privately-held biotechnology company focused on creating a library of novel derivative psychedelic molecules.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Parabase Genomics
Parabase Genomics is a molecular diagnostics company that focuses on the development of treatments for genetic disorders.
Regeneron
Regeneron Pharmaceuticals is a biotechnology company that invents life-transforming medicines for people with serious diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Vaccinex
Vaccinex is a biotechnology company engaged in the development of novel therapeutic antibodies for neurodegenerative disorders and oncology.
Verenium
Verenium is an industrial biotechnology company specializing in the development of high performance enzymes.
Vision Genomics
Vision genomics, LLC is a biotechnology company that focuses on research and development of therapeutics for age-related eye diseases.
ZaBeCor Pharmaceuticals
ZaBeCor Pharmaceuticals, LLC, a clinical stage biotechnology company, focuses on the development of siRNA, antisense, and other molecular
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Eli Lilly
Eli Lilly investment in Post-IPO Equity - Dicerna Pharmaceuticals
Cowen Group
Cowen Group investment in Post-IPO Equity - Dicerna Pharmaceuticals
Skyline Ventures
Skyline Ventures investment in Post-IPO Debt - Dicerna Pharmaceuticals
Domain Associates
Domain Associates investment in Post-IPO Debt - Dicerna Pharmaceuticals
RA Capital Management
RA Capital Management investment in Post-IPO Debt - Dicerna Pharmaceuticals
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Debt - Dicerna Pharmaceuticals
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Post-IPO Debt - Dicerna Pharmaceuticals
Cormorant Asset Management
Cormorant Asset Management investment in Post-IPO Debt - Dicerna Pharmaceuticals
Abingworth
Abingworth investment in Series C - Dicerna Pharmaceuticals
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Series C - Dicerna Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-22 | Dicerna Announces New Executive Leadership Appointments |
| 2020-05-07 | Dicerna Announces Appointment of Douglas Pagàn as Chief Financial Officer |
Official Site Inspections
http://www.dicerna.com Semrush global rank: 3.63 M Semrush visits lastest month: 3.94 K
- Host name: 199.47.130.30
- IP address: 199.47.130.30
- Location: Dallas United States
- Latitude: 32.7767
- Longitude: -96.805
- Metro Code: 623
- Timezone: America/Chicago
- Postal: 75202
More informations about "Dicerna Pharmaceuticals"
Dicerna Pharmaceuticals - Crunchbase Company …
Dicerna Pharmaceuticals is a biotechnology company with a focus on the …See details»
Dicerna Pharmaceuticals, Inc. Information - RocketReach
Dicerna Pharmaceuticals, Inc. is a Pharmaceutical Manufacturing, Pharmaceuticals, and Biotechnology company located in Lexington, Massachusetts with $2.4 billion in revenue and …See details»
Dicerna - Ownership and Business Overview | Mergr
Dicerna is a biopharmaceutical company focused on discovering, developing, and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) …See details»
Dicerna Pharmaceuticals Inc - AnnualReports.com
Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the …See details»
Dicerna Pharmaceuticals - Biotechnology, Health Care Company …
Dicerna Pharmaceuticals - Company Profile Dicerna Pharmaceuticals is a biotechnology firm pioneering breakthroughs in genetic disorders and liver diseases through RNA interference …See details»
Dicerna Pharmaceuticals, Inc. - Drug pipelines, Patents, …
May 7, 2025 Dicerna Pharmaceuticals is a biotech firm that focuses on creating groundbreaking therapies for rare genetic diseases impacting the liver, as well …See details»
Dicerna - Overview, News & Similar companies | ZoomInfo.com
Dec 25, 2021 View Dicerna (www.dicerna.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Dicerna Pharmaceuticals
Feb 25, 2025 Dicerna Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative treatments for rare and devastating …See details»
Dicerna Pharmaceuticals Inc: Overview - GlobalData
Up-to-date Dicerna Pharmaceuticals Inc company overview including funding information, company profile, key statistics, peer comparison and more.See details»
Management | Dicerna Pharmaceuticals
The Investor Relations website contains information about Dicerna Pharmaceuticals's business for stockholders, potential investors, and financial analysts.See details»
DICERNA PHARMACEUTICALS, INC. - SEC.gov
Dec 31, 2020 Dicerna Pharmaceuticals, Inc. (“we,” “us,” “our,” “the Company,” or “Dicerna”) is a biopharmaceutical company focused on discovering, developing, and commercializing …See details»
Dicerna Pharmaceuticals Company Profile - Craft
Dicerna Pharmaceuticals is a clinical-stage biopharmaceutical company that focuses on the discovery and development of treatments for rare inherited diseases. It offers GalXC, a liver …See details»
Dicerna Pharmaceuticals - 2025 Company Profile & Team - Tracxn
Jun 17, 2025 Dicerna Pharmaceuticals is an acquired company based in Lexington (United States), founded in 2007 by Douglas Fambrough. It operates as a Developer of drugs by using …See details»
Dicerna Pharmaceuticals - biopharmatrend.com
Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, develops therapeutic agents in various disease areas based on dicer substrate technology …See details»
Dicerna Pharmaceuticals - Products, Competitors, Financials, …
Investors of Dicerna Pharmaceuticals include Novo Nordisk, Eli Lilly and Company, Oxford Bioscience Partners, Abingworth, Skyline Ventures and 9 more. Who are Dicerna …See details»
Dicerna Pharmaceuticals 2025 Company Profile: Valuation, …
Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, cardiovascular diseases, …See details»
Dicerna Pharmaceuticals, Inc. Company Profile | Lexington, MA ...
Find company research, competitor information, contact details & financial data for Dicerna Pharmaceuticals, Inc. of Lexington, MA. Get the latest business insights from Dun & Bradstreet.See details»
Dicerna Pharmaceuticals, Inc. Company Profile & Data: stocks, …
Dec 1, 2021 Company Profile of Dicerna Pharmaceuticals, Inc. with information on the company's activities, financials, digital presence, market capitalization, stocks and stock …See details»
Dicerna Pharmaceuticals, Inc. - LinkedIn
Dicerna Pharmaceuticals, Inc. | 31,221 followers on LinkedIn. Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to ...See details»
Dicerna Pharmaceuticals - Profiles & Contacts - Crunchbase
Dicerna Pharmaceuticals is a biotechnology company with a focus on the development of innovative treatments for rare inherited diseases.See details»